Electrical cardiometry

A non-invasive cardiac output monitor which uses electrical cardiometry (Cardiotronic, Inc.)

Electrical cardiometry is a method based on the model of Electrical Velocimetry, and non-invasively measures stroke volume (SV), cardiac output (CO), and other hemodynamic parameters through the use of 4 surface ECG electrodes. Electrical cardiometry is a method trademarked by Cardiotronic, Inc., and is U.S. FDA approved for use on adults, children, and neonates.[1]

Overview

Electrode array for measuring TEB

Theory

The measured bioimpedance over time can be expressed as the superposition of three components:[3]

where Z0 is the quasi-static portion of the electrical impedance (base impedance), ΔZR are the changes of impedance due to the respiratory cycle, and ΔZC are the changes of impedance due to the cardiac cycle. ΔZR is considered an artifact akin to the estimation of stroke volume and is therefore suppressed. Exclusion of derived volumetric data may diminish the overall product.

The timely measurement of ΔZC (dZ(t)) reveals a waveform with shape similar to an arterial pressure waveform. The calculated first time derivative of dZ(t) is the waveform, which contains landmarks that allow determination of left-ventricular ejection time (LVET) and peak aortic blood acceleration. The peak aortic blood acceleration occurs at the steepest slope of the dZ(t) waveform, and at the peak of the waveform.

Electrical velocimetry

Electrical velocimetry (EV) is the model which electrical cardiometry is based. EV is based on the fact that the conductivity of the blood in the aorta changes during the cardiac cycle. EV was developed by Dr. Bernstein and Dr. Osypka in 2001, as a new model for interperating the bioimpedance signals of the thorax.[3]

Timely course of parallel recordings of ECG, impedance waveforms, and their relationships to RBC orientation

Prior to opening of the aortic valve, the red blood cells (erythrocytes) assume a random orientation (there is no blood flow in the aorta). When the electric current is applied from the outer electrodes, the current must circumference these red blood cells, therefore resulting in a higher voltage measurement, and thus, a lower conductivity. Shortly after aortic valve opening, the pulsatile blood flow forces the red blood cells to align in parallel with the blood flow. When the electric current is then applied, it is able to easily pass the red blood cells in the aorta resulting in a lower voltage, and thus, a higher conductivity. The change from random orientation to alignment of red blood cells upon opening of aortic valve generates a characteristic steep increase of conductivity or dZ(t) (corresponding to a steep decrease of impedance) – beat to beat.[3]

The model considers the peak amplitude of divided by the base impedance Z0 as an index for peak aortic acceleration, and as an index of contractility of the heart, or ICON. The general equation for estimating stroke volume by means of thoracic electrical bioimpedance calculates the product of a patient constant CP (in ml), the mean blood velocity index FT (measured in s−1 during flow time, and FT (flow time measured in s):[3]

The model of electrical velocimetry derives the mean blood velocity index FT from the measured index for peak aortic acceleration ICON.[4] The higher the mean blood velocity during flow time, the more SV the left ventricle ejects. The 'volume of electrically participating tissue' (VEPT) is used as the patient constant. The VEPT is derived primarily from the body mass.[3]

Comparisons

Impedance Cardiography

Impedance cardiography is a method of non-invasively monitoring hemodynamics, through the use of 4 dual sensors placed on the neck and chest. Both Impedance cardiography and Electrical Cardiometry derive SV and CO from measurements of TEB, but the underlying model is what differs. The Impedance Cardiography model contributes the rapid change of bioimpedance which occurs shortly after aortic valve opening to the expansion of the compliant ascending aorta, assuming that more blood volume temporarily stored in the ascending aorta contributes to a decrease in bioimpedance (or an increase in conductity of the thorax). The underlying model never proved accurate in patients with small cardiac outputs, hence it was never U.S. FDA approved for use in children or neonates.

Parameters

The electrical and impedance signals are processed, and then utilized to measure and calculate hemodynamic parameters such as cardiac output, stroke volume, systemic vascular resistance, thoracic fluid index, ICON (index of contractility), and systolic time ratio.

Parameter Definition
Heart rate Number of heart beats each minute
Cardiac output Amount of blood pumped by the left ventricle each minute
Cardiac index Cardiac output normalized for body surface area
Stroke volume Amount of blood pumped by the left ventricle each heartbeat
Stroke volume variation Variation of Stroke Volume beat to beat
Stroke index Stroke volume normalized for body surface area
Systemic vascular resistance The resistance to the flow of blood in the vasculature (often referred to as “Afterload”)
Systemic vascular resistance index Systemic vascular resistance normalized for body surface area
ICON Index of contractility. Peak acceleration of blood flow in the aorta
VIC Variation of ICON
Thoracic fluid index The electrical conductivity of the chest cavity, which is primarily determined by the intravascular, intraalveolar, and interstitial fluids in the thorax
Left cardiac work An indicator of the amount of work the left ventricle must perform to pump blood each minute
Systolic time ratio The ratio of the electrical and mechanical systole
Pre ejection period The time interval from the beginning of electrical stimulation of the ventricles to the opening of the aortic valve (electrical systole)
Left ventricular ejection time The time interval from the opening to the closing of the aortic valve (mechanical systole)

References

  1. U.S. 510K #K082242
  2. 1 2 http://cardiotronic.net/en/products/cardiac_output_monitors/bottom.htm
  3. 1 2 3 4 5 Bernstein DP, Osypka MJ. Apparatus and method for determining an approximation of the stroke volume and the cardiac output of the heart. US Patent No. 6,511,438.
  4. U.S. Patent Number 6,511,438 and international patents
This article is issued from Wikipedia - version of the 6/4/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.